The emerging therapy of the medication represents a major advance in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide022096.vidublog.com/40657723/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment